Novolog

Name

Novolog

Legal name

Novolog (Pharm-Up 1966) Ltd.

Website

https://novolog.co.il

Company type

Public

Founded year

1966

Operating status

Operating

Headcount range

501–1,000 employees

Ownership category

akta.pro rank

Product category

Healthcare Logistics & Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Offices of Physicians, Mental Health Specialists (621112), Software Publishers (51321)

SIC

Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011), In Vitro & In Vivo Diagnostic Substances (2835), Services-Skilled Nursing Care Facilities (8051)

akta.pro primary industry

Sample Logistics, Biorepository & IVD Kit Management (Trial Support) (HLAGAEAI)

akta.pro secondary industries

DTx/SaMD Deployment, Integration & Reimbursement Enablement (HLACANAO), DTx/SaMD Regulatory, Quality & Compliance Software (QMS/ISO/FDA) (HLACANAN), Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software (HLACANAD)

Keywords

• Pharmaceutical logistics
• Healthcare services
• Digital health platforms
• Home hospitalization
• Clinical trial services

Headquarters

HQ city

Modi'in

HQ country

Israel

HQ region

Middle East

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Logistics Division Revenue: Provides logistics services to multinational pharmaceutical and medical equipment companies including drug distribution, clinical trial logistics, pharmaceutical services, and sterilization of disposable medical equipment. Revenue from logistics division was 1,281.7 million ILS in 2022.
2. Healthcare Services Division Revenue: Provides comprehensive healthcare services to institutional and private clients including home hospitalization, ophthalmology services, laboratory services, hospice care. Revenue from healthcare services was 201.9 million ILS in 2022.
3. Digital Division Revenue: Provides digital health platforms and services including Infomed website, telemedicine solutions, and digital tools for patient-physician communication. Revenue from digital division was 26.0 million ILS in 2022.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Core offering

Novolog is an Israeli health logistics and services group that provides pharmaceutical distribution and clinical trial logistics to multinational pharma companies, comprehensive healthcare services (home hospitalization, ophthalmology, hospice, laboratory, diagnostics) to institutional and private clients, and digital health platforms (Infomed, Symptomi AI chatbot, Optio) connecting patients with medical information, physicians, and clinical trials.

Product overview

Novolog operates as a multi-divisional healthcare services group comprising three business units — Logistics, Healthcare, and Digital — along with several acquired brands. The Logistics division serves as a strategic partner for global pharmaceutical and medical device companies operating in Israel. The Healthcare division provides comprehensive health services to institutional and private clients, encompassing home hospitalization and hospice care (Mediquip), a personalized medical management center (Salus), an ophthalmology institute (Ein Tal), genetic diagnostic laboratories (Pronto Diagnostics, AML), and a pharmacy brand (MediCare Until Home). The Digital division operates platforms including Infomed (health information portal), Odoru, Doctors, and VDOC, alongside AI-powered tools such as the Symptomi chatbot developed with startup Kahun. Optio, under the Trialog sub-brand, connects chronic disease patients with clinical trials. GSAP Biomed provides regulatory and clinical trial services. The overall offering is a platform-plus-multiple-specialized-services model rather than a single unified product.

Differentiator

Problem solved

Functional benefit

Brands

• Infomed: Digital health platform providing medical information to the public, doctor-patient communication, and appointment scheduling.
• Optio
• Salus
• Medikar Ad HaBayit

Products and services

• Infomed Healthcare information portal providing medical content to the general public, including a dedicated zone for safe gynecological care recommendations, and serving as the host platform for the Symptomi AI chatbot. Targeted at Israeli patients and consumers seeking medical information.
• Symptomi AI chatbot developed with startup Kahun, deployed on the Infomed website, enabling patients to conduct intelligent self-guided preliminary medical inquiries before their physician visit, dynamically generating relevant follow-up questions and producing a structured patient summary. For Israeli patients and consumers.
• Optio Platform from Novolog's Trialog division that connects chronic disease patients with suitable clinical trials using digital tools and social media, offering a digital triage system to help patients find appropriate trials free of charge. For chronic disease patients and clinical trial sponsors.
• Salus Personalized medical management center — Israel's first of its kind — where a team of 40 specialist physicians across disciplines operates under a single personal medical manager who coordinates comprehensive, data-driven and genetically-informed care for healthy individuals, chronic disease patients, and seniors.
• Ein Tal Eye Institute Private ophthalmology center with over 35 years of reputation, featuring 60+ leading ophthalmologists performing over 10,000 surgeries annually across all eye care domains, with four surgical suites and dedicated treatment rooms. Also holds 50% stake in Ein Tal Hadassah laser eye surgery network.
• Pronto Diagnostics Operates clinical laboratories for molecular genetic diagnostics of humans, onco-genetic tests, pregnancy tests such as NIPT, genetic sequencing tests, and virus and bacteria diagnostics, as well as selling kits and reagents for molecular genetic diagnostics.
• GSAP Biomed Israeli company providing comprehensive services to biomed, pharma, medical device, and life sciences companies covering regulatory affairs, quality assurance and control, clinical trials, and complementary services throughout the product lifecycle. For biotech, pharmaceutical, and medical device companies.
• American Medical Laboratories (AML) Medical laboratory services brand acquired by Novolog, operating within the Healthcare Division and synergizing with other diagnostic activities, providing clinical laboratory services.
• Home Hospitalization & Hospice Services Home-based medical treatment and hospice care services operated by Novolog's Healthcare Division, serving thousands of customers nationwide in collaboration with all health funds, government ministries, and insurance companies, including dedicated COVID-19 home care during the pandemic.
• MediCare Until Home (Medikar Ad HaBayit) Pharmacy from Novolog specializing in dispensing medications to insurance company patients and medical tourism clients, and supplying medical preparations to various clinics.
• Pharmaceutical Logistics Services Logistics division providing comprehensive supply chain solutions for multinational pharmaceutical and medical equipment companies operating in Israel, including drug distribution, clinical trial logistics, pharmaceutical services, and sterilization of disposable medical equipment. For multinational pharma and medical device firms.
• Odoru Digital platform under the Digital Division, alongside Infomed, Doctors, and VDOC, providing digital solutions for patients and healthcare providers.
• VDOC Digital platform under the Digital Division, alongside Infomed, Odoru, and Doctors, providing digital solutions for patients and healthcare providers.

Quantifiable outcome

• 10% revenue growth to 413 million ILS in Q1 2023
• +4 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature3 records

Partnerships

Four partnerships are on record, tiered core.

• Optio (Curesponse)coreStrategic or Co-development Partner · 12 May 2022Optio platform developed by Novolog connects patients with chronic diseases to appropriate clinical trials using advanced digital tools and social networks for improved patient recruitment to medical research.
• All Israeli HMOscoreStrategic or Co-development Partner · 12 May 2022Partnership with all health maintenance organizations in Israel for home hospitalization services, laboratory services, and various healthcare delivery programs.
• Kahuna (Startup)coreTechnology or Integration · 21 December 2021Partnership with AI startup Kahuna to launch 'Symptomi' - an innovative chatbot for smart self-assessment of symptoms. The platform enables preliminary medical inquiries without human contact, using Kahuna's algorithm to dynamically generate relevant follow-up questions for improved diagnosis.
• Israeli Ministry of HealthcoreStrategic or Co-development Partner · 1 January 2020Partnership with Ministry of Health for national health projects including COVID-19 testing, vaccination campaigns. Novolog operated national vaccination centers including evening facilities for youth vaccination.

Scale indicators12 records

Recent moves6 records

Expansion highlights6 records

Regional players

• Teva Pharmaceutical Industries: Israeli-headquartered multinational pharma giant; shares Israeli origin and serves as one of the multinational pharma customers whose logistics Novolog handles, providing a structural relationship and comparable Israel-based operations footprint.
• Perrigo Company: Israel-based global consumer healthcare and generics company; shares Israeli heritage and pharma-adjacent operations with Novolog, though focused on manufacturing rather than distribution/services.

Emerging players

• Teladoc Health: Global leader in telemedicine and virtual care delivery; comparable to Novolog's Digital division (Infomed, Symptomi, telemedicine services) in providing digital patient-physician connectivity, though at much larger scale.

Broad incumbents

• Cencora (formerly AmerisourceBergen): One of the largest US pharmaceutical distributors offering drug distribution, consulting, and specialty services; parallels Novolog's pharma logistics and clinical trial services, though at vastly greater scale.
• McKesson Corporation: Global pharmaceutical distribution and healthcare services giant; comparable to Novolog's Logistics division in pharma/medical device distribution but operating at much greater scale across multiple geographies.
• Cardinal Health: Major US pharmaceutical and medical product distributor; highly comparable business model to Novolog's logistics core, including distribution, sterilization-adjacent services, and clinical solutions.

Direct peers

• Owens & Minor: Medical/surgical product distribution and supply chain services company; closely comparable to Novolog's medical equipment distribution and home-hospitalization logistics business.
• Henry Schein: Healthcare distributor serving physician offices, dental, and animal health with logistics + technology solutions; comparable to Novolog's pharma/medical device distribution combined with digital practice tools.
• Mediq: European healthcare services and medical device provider focused on home care, wound care, and medical equipment distribution; directly comparable to Novolog's home hospitalization, hospice, and medical equipment business.

Others

• Clalit Health Services: Largest Israeli HMO and a key customer of Novolog; included as an ecosystem participant representing the buyer side that defines demand for Novolog's home hospitalization, lab, and digital health services in Israel.

Market position

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/Novolog-Group-285353635695351
• LinkedInlinkedin.com/company/novolog

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Novolog